Sigma Planning Corp Intellia Therapeutics, Inc. Transaction History
Sigma Planning Corp
- $3.18 Billion
- Q2 2025
A detailed history of Sigma Planning Corp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 10,616 shares of NTLA stock, worth $138,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,616Holding current value
$138,751% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
340Shares Held
97MCall Options Held
1.66MPut Options Held
1.05M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$170 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$125 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$53.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$52.8 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $993M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...